Evidence-based translation project develops a standardized GLP-1 weight loss protocol incorporating prescribing, monitoring, lifestyle, and dose optimization guidelines.
Key findingEvidence-based translation project develops a standardized GLP-1 weight loss protocol incorporating
What the researchers found
Evidence-based translation project develops a standardized GLP-1 weight loss protocol incorporating prescribing, monitoring, lifestyle, and dose optimization guidelines.
Why it matters
Relevant to the expanding applications of peptide-based therapies in medicine.
The numbers in context
Translational project implementing semaglutide-based weight loss protocol with motivational interviewing in primary care.
How the study worked
Study methodology detailed in the full publication.
Who was studied
Primary care patients with obesity receiving semaglutide and motivational interviewing
What this study cannot tell us
Limitations discussed in the full publication.
How to read the evidence
Evidence level based on study design.
When this study was published
Published in 2025.
The bigger picture
Contributes to the growing body of evidence for peptide therapeutics across medical specialties.
Questions still open
- What are the long-term implications?
- How do results compare to existing evidence?
- What research is needed next?
Common questions
What does this mean for patients?
How reliable is this?
Read the original research
GLP-1 Weight Loss Protocol: An Evidence-Based Translation Project.
Journal of doctoral nursing practice
Citation
Allred, Meghan. (2025). GLP-1 Weight Loss Protocol: An Evidence-Based Translation Project.. Journal of doctoral nursing practice. https://doi.org/10.1891/JDNP-2024-0021